Laboratory Diagnosis and Surveillance of Thyroid Cancer


Thyroid carcinomas encompass a diverse group of malignancies with varying patient presentations, often featuring thyroid nodules. Diagnostic workup involves thyroid lab tests, imaging studies, and fine-needle aspiration. Treatment depends on carcinoma type, commonly involving surgical excision, radioactive iodine, or other modalities. Prognosis is generally favorable with high survival, necessitating long-term surveillance. Lab tests are crucial for monitoring treatment and possible disease recurrence. Thyroglobulin interpretation faces interferences; therefore, testing methods and optimal laboratory utilization are vital.

Originally published on March 28, 2024

Lecture Presenter

Adam Lyle, DO

Adam Lyle, DO

Pathology Resident, PGY 2
University of Utah School of Medicine

Dr. Adam Lyle earned his DO from Touro University California. Previously, he completed a BS in economics at Westminster College and had a career in finance.


After this presentation, participants will be able to:

  • Explain the presentation, workup, treatment, and prognosis of thyroid carcinomas
  • Describe the laboratory tests used to monitor thyroid cancer treatment, recurrence, and the impact of certain autoantibodies on these assays
  • Compare and contrast thyroid cancer testing strategies and their implications for healthcare resources

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories